Skip To Main Content
UKHSA Respiratory on Muck Rack

UKHSA Respiratory

As seen in: Journal of Infection
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with UKHSA

Contact UKHSA, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Antenatal pertussis vaccine effectiveness in England remains high post COVID-19

|
By David Litt Verified, UKHSA Immunisation, UKHSA Respiratory, Sharif A Ismail, Gayatri Amirthalingam, Nick Andrews, Helen McCready Campbell
| Journal of Infection Verified
Keywords Vaccinations pertussis vaccine effectiveness statistics respiratory paediatrics Introduction In England, a resurgence of 14,879 confirmed pertussis cases occurred in 2024, with the UK Health Security Agency (UKHSA) declaring a pertussis incident in May 2024 [1]. High activity occurred across all ages and geographical areas. The highest disease rates were in infants aged under 3 months in whom eleven deaths arose in 2024 [1,2].
Open in Who Shared Issue with article?
See all 1 articles